ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Edgardo R. Parrilla Castellar, Elaine S. Jaffe, Jonathan W. Said, Steven H. Swerdlow, Rhett P. Ketterling, Ryan A. Knudson, Jagmohan S. Sidhu, Eric D. Hsi, Shridevi Karikehalli, Liuyan Jiang, George Vasmatzis, Sarah E. Gibson, Sarah Ondrejka, Alina Nicolae, Karen L. Grogg, Cristine Allmer, Kay M. Ristow, Wyndham H. Wilson, William R. Macon, Mark E. LawJames R. Cerhan, Thomas M. Habermann, Stephen M. Ansell, Ahmet Dogan, Matthew J. Maurer, Andrew L. Feldman

Research output: Contribution to journalArticlepeer-review

230 Scopus citations

Fingerprint

Dive into the research topics of 'ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds